Read + Share
Amedeo Smart
Independent Medical Education
Munshi M, Liu X, Kofides A, Tsakmaklis N, et al. ERK1/2 pro-survival signalling is suppressed by pirtobrutinib in ibrutinib-resistant MYD88-mutated lymphoma cells. Br J Haematol 2024 Sep 18. doi: 10.1111/bjh.19756.PMID: 39295138
Email
LinkedIn
Privacy Policy